Tech Company Financing Transactions
Paratek Pharmaceuticals Funding Round
Aisling Capital, D. E. Shaw Group and HBM Healthcare Investments invested in a $18 million capital raise for Paratek Pharmaceuticals. The round was announced on 4/16/2008.
Transaction Overview
Company Name
Announced On
4/16/2008
Transaction Type
Venture Equity
Amount
$18,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. This is part of a $40 million funding.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
75 Kneeland St. 4th Floor
Boston, MA 02111
USA
Boston, MA 02111
USA
Phone
Website
Email Address
Overview
Paratek Pharmaceuticals, Inc. is a privately held biopharmaceutical company headquartered in Boston, MA, which is engaged in the discovery and commercialization of new therapeutics that treat life threatening infectious and other serious diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Bigham
Chief Financial Officer
Douglas Pagán
Chief Operating Officer
Adam Woodrow
President
Evan Loh
VP - Bus. Development
Evan Tzanis
VP - General Counsel
William Haskel
VP - Human Resources
Regina Paglia
VP - Regulatory Affairs
Randy Brenner
Browse more venture capital transactions:
Prev: 4/15/2008: StarCite venture capital transaction
Next: 4/16/2008: Central Desktop venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record every notable VC transaction. All VC database entries on this site are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs